Skip to main content

Steroids — Perioperative Management

For the reconstructive urologist, steroid decision-making falls into three overlapping scenarios: chronic glucocorticoid use (renal transplant, IBD, rheumatologic disease, interstitial cystitis, chronic asthma/COPD) requiring stress-dose coverage; dexamethasone as a perioperative adjunct for PONV, anti-inflammation, and ERAS compliance; and the wound-healing and infection consequences of chronic steroids after reconstruction (urethroplasty take, prosthetic infection risk, anastomotic leak). This article covers all three, built on the 2024 European Society of Endocrinology / Endocrine Society Joint Clinical Guideline on glucocorticoid-induced adrenal insufficiency.[4]

See also: Immunosuppression, Nausea & Vomiting, Wound Healing, ERAS.

Who Is at Risk for Perioperative Adrenal Insufficiency​

Chronic exogenous glucocorticoids suppress the HPA axis. The risk of adrenal crisis under surgical stress depends on dose, duration, and route:[4]

Likely Suppressed (Assume Need for Stress Dosing)​

  • Prednisone ≥5 mg/day (or equivalent) for ≥3 weeks in the last year
  • Cushingoid features on exam
  • Prior known adrenal insufficiency (primary, secondary, or tertiary)
  • Recent taper from chronic high-dose steroids

Indeterminate (Consider Biochemical Assessment if Feasible)​

  • Prednisone 5–10 mg/day for several weeks
  • Prolonged high-dose inhaled corticosteroid (e.g., fluticasone >880 μg/day)
  • Prolonged high-potency topical steroid over large surface area
  • Repeated intra-articular injections

Unlikely Suppressed (No Stress Dose Needed)​

  • Prednisone <5 mg/day regardless of duration
  • Any steroid use for <3 weeks
  • Standard-dose inhaled or topical steroids
  • Single recent short course (unless repeated)

Biochemical assessment (when uncertain and time permits): morning cortisol before 9 AM. A level >15–18 μg/dL rules out adrenal insufficiency; <3 μg/dL confirms it; intermediate values warrant a low-dose (1 μg) or standard (250 μg) cosyntropin stimulation test. In practice, if stress dosing is being considered in a patient likely to need surgery within a useful window, empirically cover rather than defer — the risk of adrenal crisis exceeds the low risk of a few days of supplementation.

Core Principle​

All patients on chronic glucocorticoids should continue their usual daily dose perioperatively, regardless of dose or chronicity.[1][2] Additional stress-dose steroids are then layered on top, calibrated to surgical complexity and baseline dose.

The working rule: don't let them miss their usual dose + cover the extra stress.

Stress-Dose Regimens by Surgical Complexity​

Based on the 2024 ESE / Endocrine Society Joint Clinical Guideline.[4]

Minor Stress — Minor Surgery / Local Anesthesia​

Examples for urology: cystoscopy, stent exchange, intravesical therapy, scrotal surgery under local, office-based procedures.

  • Patients already on hydrocortisone ≥40 mg/day, prednisone ≥10 mg/day, or dexamethasone ≥1 mg/day: no dose increase needed unless hemodynamic instability develops.
  • Lower doses or non-daily users: increase to hydrocortisone 40 mg total the day of procedure (20 mg 1 h before + 10 mg at 6 h + 10 mg at 12 h).
  • Continue increased dose if the patient remains unwell.

Moderate to Major Stress — General or Regional Anesthesia, Short Recovery​

Examples for urology: TURP, TURBT, pyeloplasty, moderate urethroplasty, ureteral reimplant, robotic pyeloplasty or partial nephrectomy, RARP.

Intraoperative:[4]

  • Hydrocortisone 100 mg IV bolus at induction
  • Then continuous hydrocortisone 200 mg/24 h infusion
  • If infusion not feasible: hydrocortisone 50 mg IV q6 h

Postoperative:[4]

  • Resume oral glucocorticoid at increased dose for 48 h:
    • Hydrocortisone 40 mg/day in 3 divided doses, or
    • Prednisone 10 mg/day, or
    • Dexamethasone 1 mg once daily
  • Then resume pre-surgical dose.
  • If complications develop (pain, infection, fever): maintain the increased oral dose or continue IV stress-dose coverage.

Major Stress — Surgery With Prolonged NPO or Long Recovery​

Examples for urology: radical cystectomy with urinary diversion, major pelvic reconstruction with bowel, open nephrectomy with IVC thrombus, complex posterior urethroplasty, emergency urologic surgery in a septic patient.

Intraoperative: same as moderate (100 mg IV bolus + 200 mg/24 h infusion).

Postoperative:[4]

  • Continue hydrocortisone 200 mg/24 h IV while NPO.
  • Once eating and uncomplicated: resume oral glucocorticoids at 2–3× basal dose, then taper to pre-surgical dose over 2–3 days.
  • Continue elevated dose if complications (sepsis, re-operation, prolonged ICU stay).

Important Exception — the Already-Stress-Dosed Patient​

Patients already on hydrocortisone ≥200 mg/day, prednisone ≥50 mg/day, or dexamethasone ≥6–8 mg/day at baseline do not need further dose increases unless hemodynamic instability develops.[4] They are already on pharmacologically supraphysiologic doses.

Special Situations​

Labor and Vaginal Delivery​

  • Hydrocortisone 100 mg IV bolus at onset of labor.
  • Then 50 mg IV q6 h or continuous 200 mg/24 h infusion.[3][4]

Cesarean Section​

  • Treat as major-stress NPO regimen (see above).

Septic Patient / Intraoperative Hemodynamic Decompensation​

  • Hydrocortisone 100 mg IV immediately for any unexplained, fluid-unresponsive hypotension in a known or suspected steroid-dependent patient before, during, or after surgery.[2][3][5]
  • Do not wait for biochemical confirmation — the risk of treating an uninterrupted stress response is minimal, and the risk of untreated adrenal crisis is death.

Inhaled / Topical / Intra-Articular Steroids​

  • Standard inhaled or topical doses rarely cause clinically meaningful HPA suppression.
  • High-dose fluticasone (>880 μg/day) or repeated intra-articular steroid injections have case reports of adrenal suppression — consider biochemical assessment before major surgery.

Adrenal Crisis — Recognition and Treatment​

An underappreciated perioperative emergency. Mortality is high when missed, near-zero when treated promptly.[5]

Recognition​

  • Unexplained hypotension unresponsive to fluid resuscitation
  • Shock without another clear etiology
  • Abdominal pain, nausea, vomiting
  • Hyponatremia, hyperkalemia
  • Hypoglycemia
  • Fever
  • Altered mental status

In a postoperative patient on chronic steroids with any of these findings — especially shock without response to volume — adrenal crisis is on the differential.

Treatment​

Do not wait for labs.

  1. Hydrocortisone 100 mg IV immediate bolus.
  2. Aggressive IV fluid resuscitation — normal saline, 1 L in the first hour, then as needed.
  3. Dextrose if hypoglycemic.
  4. Continue hydrocortisone 200 mg/24 h IV infusion (or 50 mg q6 h).
  5. Identify and treat the precipitating stressor — infection, MI, bleeding, missed dose.
  6. Draw cortisol and ACTH before the first dose if feasible, but never delay treatment for labs.
  7. Transition to oral hydrocortisone as patient stabilizes and can tolerate PO.

Once the crisis resolves, the patient should be educated on steroid emergency injection training (100 mg hydrocortisone IM auto-injector) and wear an emergency ID bracelet.

Dexamethasone as Perioperative Adjunct​

Single-dose IV dexamethasone (typically 4–8 mg at induction) is one of the most commonly used anesthetic adjuncts for several reasons:[4]

  • PONV prophylaxis — reduces 24 h PONV; first-line component of dual/triple antiemetic bundles for Apfel score ≥2 (see Nausea & Vomiting)
  • Anti-inflammatory — part of multimodal analgesia
  • Adjunctive analgesia — prolongs nerve block duration when given with local anesthetic

Safety signals:

  • Transient hyperglycemia — particularly relevant in diabetics; coordinate with glucose management (see Diabetes)
  • No increase in SSI from a single intraoperative 4–8 mg dose in meta-analysis
  • No effect on wound healing at single-dose perioperative amounts
  • Beware additive PONV reduction from multiple corticosteroids — a stress-dosed patient does not additionally need 8 mg dexamethasone at induction; the stress dose covers the antiemetic effect

Steroid Effects on Wound Healing and Reconstruction​

This is the urology-specific concern.

Mechanism​

Chronic glucocorticoids impair:

  • Fibroblast proliferation and collagen synthesis
  • Neutrophil and macrophage function
  • Epithelialization
  • Angiogenesis
  • Neutrophil chemotaxis (increasing SSI risk)

Clinical Consequences in Reconstructive Urology​

  • Buccal mucosal graft take — impaired in patients on chronic >10 mg/day prednisone equivalent
  • Urethroplasty anastomotic healing — slower; higher re-stricture rate
  • Prosthetic implant infection risk — AUS, IPP, sling — chronic steroids elevate infection rates independent of diabetes
  • Wound dehiscence after cystectomy / open nephrectomy
  • Bowel anastomotic leak — chronic >20 mg/day prednisone is an independent risk factor (see Bowel Anastomosis)
  • Osteoporosis — relevant for pelvic reconstructive surgery, vertebral compression fracture risk during positioning

Preoperative Mitigation Where Possible​

  • Taper to lowest effective dose in coordination with the prescribing specialist before elective reconstruction.
  • Optimize vitamin D and calcium status.
  • Document informed consent regarding elevated wound-healing and infection risk.
  • For elective prosthetic urology — consider deferral until steroid can be tapered below 10 mg/day prednisone equivalent.

Evidence and Controversy​

The evidence base for routine stress-dose steroids is limited and dated.[1][2] Recent physiologic studies suggest chronic high-dose steroid users may retain ability to increase endogenous cortisol in response to surgical stress. However:

  • The consequences of untreated adrenal crisis are catastrophic.
  • The cost and harm of stress-dose coverage is low.
  • Current guidelines favor cautious stress-dose coverage for moderate to major surgery.

Population data show a sharp mortality increase in the first 3–6 months after discontinuation of long-term oral glucocorticoids, with hypotension, GI symptoms, hypoglycemia, and hyponatremia — a reminder that the biggest risk window is after an abrupt stop, not during routine therapy.[4]

GU-Specific Quick Reference​

ScenarioApproach
Renal transplant patient (typically on prednisone 5 mg/day) undergoing elective reconstructive urologyContinue daily dose + moderate-stress regimen (100 mg HC at induction + 200 mg/24 h if open / major, 50 mg q6 h if MIS); taper off stress dose by POD 2
Chronic IBD patient on prednisone 15 mg/day for cystectomyContinue daily dose + major-stress NPO regimen; transition to oral 2–3× basal when eating
Rheumatoid arthritis patient on prednisone 7.5 mg/day for pyeloplastyContinue + moderate-stress regimen
IC patient on chronic low-dose prednisone for sling revisionContinue + minor-stress (no dose increase if ≥10 mg/day equivalent)
Asymptomatic patient on fluticasone inhaled 220 μg/day for asthma undergoing RARPNo stress dose needed
Unexplained postoperative shock on prednisone historyHydrocortisone 100 mg IV immediately without waiting for biochemical confirmation

Key Recommendations​

  1. Always continue the baseline daily dose perioperatively.
  2. Layer stress dose on top, calibrated to surgical complexity.
  3. Minor surgery / local anesthesia: usually no dose increase in patients on ≥10 mg prednisone equivalent.
  4. Moderate-major surgery: hydrocortisone 100 mg IV at induction + 200 mg/24 h infusion (or 50 mg q6 h).
  5. NPO / long recovery: continue IV 200 mg/24 h until eating, then 2–3× basal oral, then taper.
  6. Already on supraphysiologic doses (≥50 mg prednisone equivalent): no additional stress dose needed.
  7. Adrenal crisis — 100 mg hydrocortisone IV immediately for unexplained shock; do not delay for labs.
  8. Dexamethasone 4–8 mg at induction is a standard PONV / anti-inflammatory adjunct; watch glucose in diabetics.
  9. Optimize chronic steroid dose downward before elective reconstruction when feasible to protect wound healing and implants.

Pharmacology Hub Companion​

For the drug-class pharmacology of corticosteroids — agent-by-agent mechanism, dose, and indication-specific evidence across PONV/ERAS, mCRPC (abiraterone co-administration, steroid switch, GR-mediated resistance), renal-transplant rejection, contrast premedication, IC/BPS Hunner-lesion prednisone, and deflazacort-MET adjunct — see Corticosteroids.

TopicWhere it lives
Chronic-steroid patient identification, stress-dose regimens, adrenal crisis, wound-healing consequencesThis article
Drug-class pharmacology of each corticosteroid, indication-specific evidence, safety ceilingsPharmacology: Corticosteroids

References​

1. Freudzon L. "Perioperative Steroid Therapy: Where's the Evidence?" Curr Opin Anaesthesiol. 2018;31(1):39–42. doi:10.1097/ACO.0000000000000547

2. Coccolini F, Improta M, Sartelli M, et al. "Acute Abdomen in the Immunocompromised Patient — WSES, SIS-E, WSIS, AAST, and GAIS Guidelines." World J Emerg Surg. 2021;16(1):40. doi:10.1186/s13017-021-00380-1

3. Vaidya A, Findling J, Bancos I. "Adrenal Insufficiency in Adults." JAMA. 2025;334(8):714–725. doi:10.1001/jama.2025.5485

4. Beuschlein F, Else T, Bancos I, et al. "European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-Induced Adrenal Insufficiency." J Clin Endocrinol Metab. 2024;109(7):1657–1683. doi:10.1210/clinem/dgae250

5. Rushworth RL, Torpy DJ, Falhammar H. "Adrenal Crisis." N Engl J Med. 2019;381(9):852–861. doi:10.1056/NEJMra1807486